|
1
|
Zhu X, Li Z, Li T, Long F, Lv Y, Liu L,
Liu X and Zhan Q: Osthole inhibits the PI3K/AKT signaling pathway
via activation of PTEN and induces cell cycle arrest and apoptosis
in esophageal squamous cell carcinoma. Biomed Pharmacother.
102:502–509. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yuan X, Liu Y, Li G, Lan Z, Ma M, Li H,
Kong J, Sun J, Hou G, Hou X, et al: Blockade of immune-checkpoint
B7-H4 and lysine demethylase 5B in esophageal squamous cell
carcinoma confers protective immunity against P. gingivalis
infection. Cancer Immunol Res. 7:1440–1456. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yuan H, Zhou W, Yang Y, Xue L, Liu L and
Song Y: ISG15 promotes esophageal squamous cell carcinoma
tumorigenesis via c-MET/Fyn/β-catenin signaling pathway. Exp Cell
Res. 367:47–55. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu L and Chen L: Progress in research on
paclitaxel and tumor immunotherapy. Cell Mol Biol Lett. 24:402019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kundranda MN and Niu J: Albumin-bound
paclitaxel in solid tumors: Clinical development and future
directions. Drug Des Devel Ther. 9:3767–3777. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scherz A, Feller K, Berezowska S, Genitsch
V and Zweifel M: Successful treatment of pituitary germinoma with
etoposide, cisplatin, vincristine, methotrexate and bleomycin
chemotherapy without radiotherapy. Anticancer Res. 37:3111–3115.
2017.PubMed/NCBI
|
|
8
|
Zhu B, Yu L and Yue Q: Co-delivery of
vincristine and quercetin by nanocarriers for lymphoma combination
chemotherapy. Biomed Pharmacother. 91:287–294. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pham DC, Chang YC, Lin SR, Fuh YM, Tsai MJ
and Weng CF: FAK and S6K1 inhibitor, neferine, dually induces
autophagy and apoptosis in human neuroblastoma cells. Molecules.
23:31102018. View Article : Google Scholar
|
|
10
|
Deng G, Zeng S, Ma J, Zhang Y, Qu Y, Han
Y, Yin L, Cai C, Guo C and Shen H: The anti-tumor activities of
Neferine on cell invasion and oxaliplatin sensitivity regulated by
EMT via Snail signaling in hepatocellular carcinoma. Sci Rep.
7:416162017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu L, Zhang X, Li Y, Lu S, Lu S, Li J,
Wang Y, Tian X, Wei JJ, Shao C and Liu Z: Neferine induces
autophagy of human ovarian cancer cells via p38 MAPK/JNK
activation. Tumour Biol. 37:8721–8729. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang X, Liu Z, Xu B, Sun Z, Gong Y and
Shao C: Neferine, an alkaloid ingredient in lotus seed embryo,
inhibits proliferation of human osteosarcoma cells by promoting p38
MAPK-mediated p21 stabilization. Eur J Pharmacol. 677:47–54. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cannell IG, Merrick KA, Morandell S, Zhu
CQ, Braun CJ, Grant RA, Cameron ER, Tsao MS, Hemann MT and Yaffe
MB: A pleiotropic RNA-binding protein controls distinct cell cycle
checkpoints to drive resistance of p53-defective tumors to
chemotherapy. Cancer Cell. 28:8312015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pan X, Liu W, Chai Y, Hu L, Wang J and
Zhang Y: Identification of Hub genes in atypical teratoid/rhabdoid
tumor by bioinformatics analyses. J Mol Neurosci. 2020:(Online
ahead of print).
|
|
15
|
Saldivar JC, Hamperl S, Bocek MJ, Chung M,
Bass TE, Cisneros-Soberanis F, Samejima K, Xie L, Paulson JR,
Earnshaw WC, et al: An intrinsic S/G2 checkpoint enforced by ATR.
Science. 361:806–810. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Foijer F, Wolthuis RM, Doodeman V, Medema
RH and te Riele H: Mitogen requirement for cell cycle progression
in the absence of pocket protein activity. Cancer Cell. 8:455–466.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu W, Chai Y, Hu L, Wang J, Pan X, Yuan
H, Zhao Z, Song Y and Zhang Y: Polyphyllin VI induces apoptosis and
autophagy via reactive oxygen species mediated JNK and P38
activation in Glioma. Onco Targets Ther. 13:2275–2288. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carneiro BA and El-Deiry WS: Targeting
apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020.(Online ahead
of print). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Al Shahrani M, Balasubramaniam M,
Alshahrani MY, Saif A, Dera AA, Alasmari S, Abohassan M, Makkawi M,
Radhakrishnan S and Rajagopalan P: Computational and in vitro
characterization of ICY-5: A potential candidate promoting
mitochondrial apoptosis via the c-MET and STAT3 pathways. J Cell
Physiol. 2020.(Online ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Buckley AM, Lynam-Lennon N, O'Neill H and
O'Sullivan J: Targeting hallmarks of cancer to enhance
radiosensitivity in gastrointestinal cancers. Nat Rev Gastroenterol
Hepatol. 17:298–313. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Del Re DP, Amgalan D, Linkermann A, Liu Q
and Kitsis RN: Fundamental mechanisms of regulated cell death and
implications for heart disease. Physiol Rev. 99:1765–1817. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Soteriou D and Fuchs Y: A matter of life
and death: stem cell survival in tissue regeneration and tumour
formation. Nat Rev Cancer. 18:187–201. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fendt SM and Lunt SY: Dynamic ROS
regulation by TIGAR: Balancing anti-cancer and pro-metastasis
effects. Cancer Cell. 37:141–142. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou Z, Song J, Nie L and Chen X: Reactive
oxygen species generating systems meeting challenges of
photodynamic cancer therapy. Chem Soc Rev. 45:6597–6626. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kahroba H, Shirmohamadi M, Hejazi MS and
Samadi N: The Role of Nrf2 signaling in cancer stem cells: From
stemness and self-renewal to tumorigenesis and chemoresistance.
Life Sci. 239:1169862019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ferino A, Rapozzi V and Xodo LE: The
ROS-KRAS-Nrf2 axis in the control of the redox homeostasis and the
intersection with survival-apoptosis pathways: Implications for
photodynamic therapy. J Photochem Photobiol B. 202:1116722020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
DeNicola GM, Karreth FA, Humpton TJ,
Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES,
et al: Oncogene-induced Nrf2 transcription promotes ROS
detoxification and tumorigenesis. Nature. 475:106–109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan D, Huang S, Berger E, Liu L, Gross N,
Heinzmann F, Ringelhan M, Connor TO, Stadler M, Meister M, et al:
Kupffer cell-derived tnf triggers cholangiocellular tumorigenesis
through JNK due to chronic mitochondrial dysfunction and ROS.
Cancer Cell. 31:771–789.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Owusu-Ansah E, Yavari A, Mandal S and
Banerjee U: Distinct mitochondrial retrograde signals control the
G1-S cell cycle checkpoint. Nat Genet. 40:356–361. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cui YJ, Ma CC, Zhang CM, Tang LQ and Liu
ZP: The discovery of novel indazole derivatives as tubulin
colchicine site binding agents that displayed potent antitumor
activity both in vitro and in vivo. Eur J Med Chem. 187:1119682020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mondal A, Gandhi A, Fimognari C, Atanasov
AG and Bishayee A: Alkaloids for cancer prevention and therapy:
Current progress and future perspectives. Eur J Pharmacol.
858:1724722019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Salehi B, Selamoglu ZS, Mileski K, Pezzani
R, Redaelli M, Cho WC, Kobarfard F, Rajabi S, Martorell M, Kumar P,
et al: Liposomal Cytarabine as Cancer Therapy: From chemistry to
medicine. Biomolecules. 9:7732019. View Article : Google Scholar
|
|
34
|
Lin JH, Ting PC, Lee WS, Chiu HW, Chien
CA, Liu CH, Sun LY and Yang KT: Palmitic acid methyl ester induces
G2/M arrest in human bone marrow-derived mesenchymal stem cells via
the p53/p21 pathway. Stem Cells Int. 2019:76062382019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kreis NN, Louwen F and Yuan J: Less
understood issues: p21(Cip1) in mitosis and its therapeutic
potential. Oncogene. 34:1758–1767. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kerr N, de Rivero Vaccari JP, Dietrich WD
and Keane RW: Neural-respiratory inflammasome axis in traumatic
brain injury. Exp Neurol. 323:1130802020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Z, Yu K, Hu Y, Su F, Gao Z, Hu T,
Yang Y, Cao X and Qian F: Schisantherin A induces cell apoptosis
through ROS/JNK signaling pathway in human gastric cancer cells.
Biochem Pharmacol. 173:1136732020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yuan YL, Jiang N, Li ZY, Song ZZ, Yang ZH,
Xue WH, Zhang XJ and Du Y: Polyphyllin VI induces apoptosis and
autophagy in human osteosarcoma cells by modulation of ROS/JNK
activation. Drug Des Devel Ther. 13:3091–3103. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zou P, Zhang J, Xia Y, Kanchana K, Guo G,
Chen W, Huang Y, Wang Z, Yang S and Liang G: ROS generation
mediates the anti-cancer effects of WZ35 via activating JNK and ER
stress apoptotic pathways in gastric cancer. Oncotarget.
6:5860–5876. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Che Y, Wang J, Yuan Z, Li Y, Lu Z, Zhang
Z, Zhang J, Wan J, Sun H, Chen Z, et al: The therapeutic effects of
Longikaurin A, a natural ent-kauranoid, in esophageal squamous cell
carcinoma depend on ROS accumulation and JNK/p38 MAPK activation.
Toxicol Lett. 280:106–115. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang X, Wang X, Wu T, Li B, Liu T, Wang
R, Liu Q, Liu Z, Gong Y and Shao C: Isoliensinine induces apoptosis
in triple-negative human breast cancer cells through ROS generation
and p38 MAPK/JNK activation. Sci Rep. 5:125792015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Guo Z, Guozhang H, Wang H, Li Z and Liu N:
Ampelopsin inhibits human glioma through inducing apoptosis and
autophagy dependent on ROS generation and JNK pathway. Biomed
Pharmacother. 116:1085242019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang H, Zhang T, Sun W, Wang Z, Zuo D,
Zhou Z, Li S, Xu J, Yin F, Hua Y and Cai Z: Erianin induces
G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK
signaling pathway in human osteosarcoma cells in vitro and in vivo.
Cell Death Dis. 7:e22472016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Banerjee N, Wang H, Wang G and Khan MF:
Enhancing the Nrf2 antioxidant signaling provides protection
against trichloroethene-mediated inflammation and autoimmune
response. Toxicol Sci. 175:64–74. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhou XL, Wu X, Zhu RR, Xu H, Li YY, Xu QR,
Liu S, Lai SQ, Xu X, Wan L, et al: Notch1-Nrf2 signaling crosstalk
provides myocardial protection by reducing ROS formation. Biochem
Cell Biol. 98:106–111. 2020. View Article : Google Scholar : PubMed/NCBI
|
